Myomo Reports 21% Revenue Growth to $11.7 Million in Q2 2026

Myomo (NYSEAMERICAN:MYO) reported Q2 2026 revenue of $11.7 million, a 21% increase from the previous year. The company achieved a gross margin of 72.1% and narrowed its operating loss to $2.3 million. Myomo's strategy shift resulted in recurring referral sources generating 53% of revenue, up from 26% a year earlier. Full-year 2026 revenue guidance was raised to $45 million–$47 million, reflecting positive momentum and increased orders, which totaled a record 255. This is important for investors as it indicates growth potential and management's confidence in future earnings.